• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SPATZ FGIA INC. SPATZ3 ADJUSTABLE BALLOON SYSTEM; GASTRIC BALLOON

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SPATZ FGIA INC. SPATZ3 ADJUSTABLE BALLOON SYSTEM; GASTRIC BALLOON Back to Search Results
Model Number A-SP3-03K
Device Problem Air/Gas in Device (4062)
Patient Problem Abdominal Pain (1685)
Event Date 01/07/2022
Event Type  malfunction  
Event Description
The patient reported abdominal discomfort.The endoscopy examination found that the balloon was over inflated, the balloon was removed and replaced.
 
Manufacturer Narrative
To date, spatz fgia inc.Has not received the product for evaluation, therefore no analysis or testing has been done.A review of the device labeling notes the following: spontaneous hyperinflation can occur in fluid-filled intragastric balloons.It is characterized by the spontaneous hyperinflation of the balloon with air causing an enlargement of the balloon, which can lead to abdominal pain, nausea and vomiting, and in severe cases it can lead to ulceration, and rarely it can cause gastric perforation and death.Any change in symptoms - new onset nausea, vomiting, pain, or trouble breathing - needs to be addressed by the physician to rule out, among other things, spontaneous hyperinflation.If a balloon is found to be hyperinflated, it should be removed.Each patient must be monitored closely during the entire term of treatment to detect the development of possible complications.Each patient should be instructed regarding signs and symptoms of balloon deflation, gastrointestinal obstruction, perforation, ulceration and other complications, which might occur, and should be advised to contact his/her physician immediately upon the onset of such signs and symptoms.Any change in symptoms - new onset nausea, vomiting, pain, or trouble breathing - needs to be addressed by the doctor.The cause may include dietary indiscretion, ulceration, hyperinflation, perforation or obstruction.In certain circumstances the doctor will choose to do an x-ray, or endoscopy, if dietary/medication changes do not alleviate symptoms.Prompt attention is recommended to prevent serious complications.Spontaneous hyperinflation occurs due to gas production within the balloon.Spontaneous hyperinflation can cause abdominal pain, nausea and vomiting, and in severe cases it can lead to ulceration, and rarely it can cause gastric perforation and death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPATZ3 ADJUSTABLE BALLOON SYSTEM
Type of Device
GASTRIC BALLOON
Manufacturer (Section D)
SPATZ FGIA INC.
1801 s perimeter rd, suite 130
fort lauderdale FL 33309
MDR Report Key14069174
MDR Text Key290456953
Report Number3012638928-2022-02525
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P190012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Distributor
Reporter Occupation Physician
Remedial Action Replace
Type of Report Initial
Report Date 03/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/10/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Expiration Date01/16/2023
Device Model NumberA-SP3-03K
Device Lot Number210116
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/14/2022
Date Device Manufactured01/15/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
Patient Weight100 KG
-
-